Mark For: GRANDE® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88409581 |
Registration Number | 6428821 |
Mark Literal Elements | GRANDE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-04-14 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Karen M. Whitney |
Attorney Docket Number | KAS0024US-01 |
Law Office Assigned | O10 |
Employee Name | SOLANO, CARLITA JAYE |
2019-04-30 | Application Filed |
2019-07-15 | Location: TMO LAW OFFICE 128 - EXAMINING ATTORNEY ASSIGNED |
2019-07-15 | Status: Live/Pending |
2019-12-19 | Transaction Date |
2020-02-18 | Published |
2020-04-14 | Location: INTENT TO USE SECTION |
2020-04-14 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
2021-07-20 | Trademark Registered |
Party: | Kashiv BioSciences, LLC |
Address | 995 U.S. Hwy 202/206 Bridgewater, NEW JERSEY UNITED STATES 08807 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | NEW JERSEY |
Drawing | IMAGE/JPEG | 2019-04-30 |
TEAS RF New Application | MULTI | 2019-04-30 |
Preliminary Amendment | APPLICATION/XML,IMAGE/JPEG | 2019-05-14 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-05-24 |
XSearch Search Summary | XML | 2019-07-11 |
Examiners Amendment Priority | MULTI | 2019-07-15 |
Response to Office Action | XML | 2020-01-10 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-01-11 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-01-14 |
Notice of Publication | XML | 2020-01-29 |
Notification Of Notice of Publication | XML | 2020-01-29 |
OG Publication Confirmation | APPLICATION/XML | 2020-02-18 |
Notice of Allowance | APPLICATION/XML | 2020-04-14 |
IC 042. US 100 101. G & S: Pharmaceutical research and development services for providing gastro-retentive drug delivery systems that provide delayed release, delayed controlled release, delayed extended release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients, release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Pharmaceutical research and development services for providing gastro-retentive drug delivery systems that provide delayed release, delayed controlled release, delayed extended release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients, release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients |
GS0421 | Pharmaceutical research and development services for providing gastro-retentive drug delivery systems that provide delayed release, delayed controlled release, delayed extended release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients, release, controlled release, or release corresponding to circadian and/or biological rhythms, of active pharmaceutical ingredients |
Description | Date | Proceeding Number |
---|---|---|
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-04-14 | |
PUBLISHED FOR OPPOSITION | 2020-02-18 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-02-18 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-01-29 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-13 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-01-10 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-01-10 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-01-10 | 88889 |
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2019-07-15 | 6326 |
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | 2019-07-15 | 94491 |
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2019-07-15 | 6326 |
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | 2019-07-15 | 94491 |
ASSIGNED TO EXAMINER | 2019-07-11 | 94491 |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2019-05-23 | 66121 |
ASSIGNED TO LIE | 2019-05-21 | 66121 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-05-17 | |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2019-05-14 | |
NEW APPLICATION ENTERED IN TRAM | 2019-05-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.